Literature DB >> 9012635

Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact.

H Gylling1, K Kontula, U M Koivisto, H E Miettinen, T A Miettinen.   

Abstract

Genetic and dietary factors regulate serum cholesterol level, but detailed investigations into their interactions have not been established. We assessed the effects of apoprotein (apo) E phenotype and polymorphic alleles of the apo A-I, apo B, apo C-III, and LDL receptor genes, separately and together, on regulation of serum LDL cholesterol level. The study group consisted of 29 middle-aged men, and cholesterol absorption, bile acid, and cholesterol synthesis and LDL apo B kinetics were studied in these men during low- and high-cholesterol diets. The six apo B alleles were identified on the basis of Xba I, EcoRI, and Msp I restriction fragment length polymorphism (RFLP), the apo A-I alleles with the Msp I RFLP, and the apo C-III and LDL receptor alleles corresponded to the Sst I and PvuII RPLPs of these genes, respectively. During low cholesterol intake, LDL cholesterol levels were similar in all of the genetic groups except for men with apo E2 phenotype. They had significantly (P < .05) lower levels of LDL apo B and cholesterol than men without the epsilon 2 allele. The low values were caused by a significantly higher removal of LDL apo B (apo E2, 0.453 +/- 0.03 versus apo E3, 0.312 +/- 0.01 pools per day, P < .05). High cholesterol intake increased LDL cholesterol levels in all genetic categories except in the apo E2 phenotype irrespective of the combinations with other polymorphisms. Carriers of the apo B R+ allele (EcoRI site present) presented with the most prominent LDL cholesterol rise (from 2.71 +/- 0.14 to 3.37 +/- 0.29 mmol/L). In multiple stepwise regression analysis, apo B EcoRI RFLP and apo E phenotypes were the only variables that explained the variability of high cholesterol intake-induced change in LDL cholesterol levels. In summary, in any genetic combination, individuals with the epsilon 2 allele had the lowest LDL cholesterol values and were nonresponders to dietary cholesterol, whereas subjects with the apo B R+ allele had marked LDL elevations, especially in combination with the epsilon 4.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9012635     DOI: 10.1161/01.atv.17.1.38

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

1.  Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.

Authors:  Mary K Wojczynski; Guimin Gao; Ingrid Borecki; Paul N Hopkins; Laurence Parnell; Chao-Qiang Lai; Jose M Ordovas; B Hong Chung; Donna K Arnett
Journal:  J Lipid Res       Date:  2010-08-19       Impact factor: 5.922

2.  Effects of Ava II and Hinc II polymorphisms at the LDL receptor gene on serum lipid levels of Brazilian individuals with high risk for coronary heart disease.

Authors:  L A Salazar; M H Hirata; S D Giannini; N Forti; J Diament; J S Issa; R D Hirata
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

3.  Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer.

Authors:  Ikuko Kato; Susan Land; Adhip P Majumdar; Jill Barnholtz-Sloan; Richard K Severson
Journal:  Cancer Epidemiol       Date:  2010-03-21       Impact factor: 2.984

4.  A Database of Gene-Environment Interactions Pertaining to Blood Lipid Traits, Cardiovascular Disease and Type 2 Diabetes.

Authors:  Yu-Chi Lee; Chao-Qiang Lai; Jose M Ordovas; Laurence D Parnell
Journal:  J Data Mining Genomics Proteomics       Date:  2011-01-01

5.  Macronutrient intake modulates impact of EcoRI polymorphism of ApoB gene on lipid profile and inflammatory markers in patients with type 2 diabetes.

Authors:  Faezeh Abaj; Fariba Koohdani
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

6.  APOE and FABP2 Polymorphisms and History of Myocardial Infarction, Stroke, Diabetes, and Gallbladder Disease.

Authors:  Ikuko Kato; Susan Land; Jill Barnholtz-Sloan; Richard K Severson
Journal:  Cholesterol       Date:  2011-09-18

Review 7.  The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism.

Authors:  Elaine Regina Delicato de Almeida; Edna Maria Vissoci Reiche; Ana Paula Kallaur; Tamires Flauzino; Maria Angelica Ehara Watanabe
Journal:  Biomed Res Int       Date:  2013-11-12       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.